Identification of molecular pathways facilitating Glioma cell invasion in situ

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Nevo, Ido ^a   Woolard, Kevin ^a   Cam, Maggie ^a   Li, Aiguo ^a   Webster, Joshua D ^a   Kotliarov, Yuri ^a   Kim, Hong Sug ^a   Ahn, Susie ^a   Walling, Jennifer ^a   Kotliarova, Svetlana ^a   Belova, Galina ^a   Song, Hua ^a   Bailey, Rolanda ^a   Zhang, Wei ^a   Fine, Howard A ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; HERMES ANTIGEN; LAMININ; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; TUMOR PROTEIN;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APC GENE; APP GENE; AQP4 GENE; ARTICLE; BMP7 GENE; BRAIN CORTEX; CANCER STEM CELL; CARCINOMA IN SITU; CD44 GENE; CDC20 GENE; CDC42 GENE; CDH2 GENE; CELL ADHESION; CELL INFILTRATION; CELL INVASION; CELL MIGRATION; CELL POLARITY; CHEMOTAXIS; CHI3L1 GENE; CONTROLLED STUDY; CORPUS CALLOSUM; CTNNB1 GENE; DOWN REGULATION; EPHA4 GENE; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FBXO5 GENE; FGF2 GENE; FGFR1 GENE; GENE EXPRESSION; GENE MAPPING; GLIOBLASTOMA; GLIOMA; HOST CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; MICROARRAY ANALYSIS; MITOSIS; MOUSE; NANOG GENE; NCAM1 GENE; NESTIN GENE; NONHUMAN; OCT4 GENE; OLIG2 GENE; PARD3 GENE; PLAUR GENE; PLXNA4 GENE; SEMA5A GENE; SOX2 GENE; STAT3 GENE; TGFB3 GENE; TUMOR GENE; TUMOR MICROENVIRONMENT; UPREGULATION; WISP1 GENE; WOUND HEALING; ADULT; ANIMAL; BIOSYNTHESIS; BRAIN TUMOR; CANCER TRANSPLANTATION; CELL PROLIFERATION; CLINICAL TRIAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; SCID MOUSE; TUMOR INVASION; XENOGRAFT;

ADULT; ANIMALS; BRAIN NEOPLASMS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HETEROGRAFTS; HUMANS; MALE; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; TUMOR MICROENVIRONMENT;

EID: 84909619977     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111783     Document Type: Article

References (50)

1. Li A, Walling J, Ahn S, Kotliarov Y, Su Q, et al. (2009) Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res 69:2091-2099.
2. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157-173.
3. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98-110.
4. Gritsenko PG, Ilina O, Friedl P (2012) Interstitial guidance of cancer invasion. J Pathol 226:185-199.
5. Sanai N, Alvarez-Buylla A, Berger MS (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353:811-822.
6. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, et al. (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66:9339-9344.
7. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391-403.
8. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, et al. (2005) Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7:7-16.
9. Kislin KL, McDonough WS, Eschbacher JM, Armstrong BA, Berens ME (2009) NHERF-1: modulator of glioblastoma cell migration and invasion. Neoplasia 11:377-387.
10. Ene CI, Edwards L, Riddick G, Baysan M, Woolard K, et al. (2012) Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilization. PLoS One 7:e51407.
11. Lee K, Nelson CM (2012) New insights into the regulation of epithelialmesenchymal transition and tissue fibrosis. Int Rev Cell Mol Biol 294:171-221.
12. Martin-Belmonte F, Perez-Moreno M (2012) Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 12:23-38.
13. McCaffrey LM, Montalbano J, Mihai C, Macara IG (2012) Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis. Cancer Cell 22:601-614.
14. Sturge J, Wienke D, East L, Jones GE, Isacke CM (2003) GPI-anchored uPAR requires Endo180 for rapid directional sensing during chemotaxis. J Cell Biol 162:789-794.
15. Kim S, Yu H (2011) Mutual regulation between the spindle checkpoint and APC/C. Semin Cell Dev Biol 22:551-558.
16. Meijer DH, Kane MF, Mehta S, Liu H, Harrington E, et al. (2012) Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2. Nat Rev Neurosci 13:819-831.
17. Moshe Y, Bar-On O, Ganoth D, Hershko A (2011) Regulation of the action of early mitotic inhibitor 1 on the anaphase-promoting complex/cyclosome by cyclin-dependent kinases. J Biol Chem 286:16647-16657.
18. Waimey KE, Huang PH, Chen M, Cheng HJ (2008) Plexin-A3 and plexin-A4 restrict the migration of sympathetic neurons but not their neural crest precursors. Dev Biol 315:448-458.
19. Wang S, Chong ZZ, Shang YC, Maiese K (2013) WISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1. Curr Neurovasc Res 10:54-69.
20. Zimmer G, Rudolph J, Landmann J, Gerstmann K, Steinecke A, et al. (2011) Bidirectional ephrinB3/EphA4 signaling mediates the segregation of medial ganglionic eminence- and preoptic area-derived interneurons in the deep and superficial migratory stream. J Neurosci 31:18364-18380.
21. Harvey BK, Hoffer BJ, Wang Y (2005) Stroke and TGF-beta proteins: glial cell line-derived neurotrophic factor and bone morphogenetic protein. Pharmacol Ther 105:113-125.
22. Juncker-Jensen A, Lund LR (2011) Phenotypic overlap between MMP-13 and the plasminogen activation system during wound healing in mice. PLoS One 6:e16954.
23. Kiss JZ, Troncoso E, Djebbara Z, Vutskits L, Muller D (2001) The role of neural cell adhesion molecules in plasticity and repair. Brain Res Brain Res Rev 36:175-184.
24. Lefort CT, Wojciechowski K, Hocking DC (2011) N-cadherin cell-cell adhesion complexes are regulated by fibronectin matrix assembly. J Biol Chem 286:3149-3160.
25. Matise LA, Palmer TD, Ashby WJ, Nashabi A, Chytil A, et al. (2012) Lack of transforming growth factor-beta signaling promotes collective cancer cell invasion through tumor-stromal crosstalk. Breast Cancer Res 14:R98.
26. Li X, Law JW, Lee AY (2012) Semaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeleton. Oncogene 31:595-610.
27. Siemes C, Quast T, Kummer C, Wehner S, Kirfel G, et al. (2006) Keratinocytes from APP/APLP2-deficient mice are impaired in proliferation, adhesion and migration in vitro. Exp Cell Res 312:1939-1949.
28. Villena J, Berndt C, Granes F, Reina M, Vilaro S (2003) Syndecan-2 expression enhances adhesion and proliferation of stably transfected Swiss 3T3 cells. Cell Biol Int 27:1005-1010.
29. Zecchini S, Bombardelli L, Decio A, Bianchi M, Mazzarol G, et al. (2011) The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling. EMBO Mol Med 3:480-494.
30. Warth A, Kroger S, Wolburg H (2004) Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae. Acta Neuropathol 107:311-318.
31. Watanabe A, Mabuchi T, Satoh E, Furuya K, Zhang L, et al. (2006) Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression. J Neurooncol 77:25-32.
32. Angot E, Loulier K, Nguyen-Ba-Charvet KT, Gadeau AP, Ruat M, et al. (2008) Chemoattractive activity of sonic hedgehog in the adult subventricular zone modulates the number of neural precursors reaching the olfactory bulb. Stem Cells 26:2311-2320.
33. Edwards LA, Woolard K, Son MJ, Li A, Lee J, et al. (2011) Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst 103:1162-1178.
34. Shah GD, Loizos N, Youssoufian H, Schwartz JD, Rowinsky EK (2010) Rationale for the development of IMC-3G3, a fully human immunoglobulin G subclass 1 monoclonal antibody targeting the platelet-derived growth factor receptor alpha. Cancer 116:1018-1026.
35. Ligon KL, Huillard E, Mehta S, Kesari S, Liu H, et al. (2007) Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 53:503-517.
36. Shen-Orr SS, Tibshirani R, Khatri P, Bodian DL, Staedtler F, et al. (2010) Cell type-specific gene expression differences in complex tissues. Nat Methods 7:287-289.
37. Dallas PB, Gottardo NG, Firth MJ, Beesley AH, Hoffmann K, et al. (2005) Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate? BMC Genomics 6:59.
38. Thomas PD, Mi H, Lewis S (2007) Ontology annotation: mapping genomic regions to biological function. Curr Opin Chem Biol 11:4-11.
39. Nevo I, Oberthuer A, Botzer E, Sagi-Assif O, Maman S, et al. (2010) Geneexpressionbased analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients. Int J Cancer 126:1570-1581.
40. Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, et al. (2003) Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci U S A 100:15901-15905.
41. Binda E, Visioli A, Giani F, Lamorte G, Copetti M, et al. (2012) The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas. Cancer Cell 22:765-780.
42. Day BW, Stringer BW, Al-Ejeh F, Ting MJ, Wilson J, et al. (2013) EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme. Cancer Cell 23:238-248.
43. Janes PW, Wimmer-Kleikamp SH, Frangakis AS, Treble K, Griesshaber B, et al. (2009) Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10. PLoS Biol 7:e1000215.
44. Siebzehnrubl FA, Silver DJ, Tugertimur B, Deleyrolle LP, Siebzehnrubl D, et al. (2013) The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med 5:1196-1212.
45. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 133:704-715.
46. Brabletz T (2012) EMT and MET in metastasis: where are the cancer stem cells? Cancer Cell 22:699-701.
47. Xu Y, Stamenkovic I, Yu Q (2010) CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma. Cancer Res 70:2455-2464.
48. Ku BM, Lee YK, Ryu J, Jeong JY, Choi J, et al. (2011) CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells. Int J Cancer 128:1316-1326.
49. Fu J, Koul D, Yao J, Wang S, Yuan Y, et al. (2013) Novel HSP90 Inhibitor NVP-HSP990 Targets Cell-Cycle Regulators to Ablate Olig2-Positive Glioma Tumor-Initiating Cells. Cancer Res 73:3062-3074.
50. Sottoriva A, Spiteri I, Piccirillo SG, Touloumis A, Collins VP, et al. (2013) Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A 110:4009-4014.